Heart Rate Variability in Schizophrenia and Shizoaffective Disorder
https://doi.org/10.31550/1727-2378-2022-21-4-72-78
Abstract
Objective of the Review: To analyze and systematize the results of the studies of heart rate variability in schizophrenia and schizoaffective disorder.
Key points. Most studies demonstrate a reduction in total heart rate variability and a decrease in parasympathetic tone and reactivity in patients with schizophrenia and schizoaffective disorder, including in response to a cognitive or stress load. And also the baroreflex sensitivity decrease was revealed. Autonomic cardiac dysregulation detected in unmedicated patients with schizophrenia, as well as in healthy first-line relatives. The extent of these changes correlates with the severity of productive, negative and affective symptoms, as well as with the presence of metabolic syndrome. Autonomic cardiac dysregulation is much more pronounced in psychotic states. Antipsychotics with anticholinergic and/or α1 -adrenolytic activity can exacerbate these changes. Reductions in total heart rate variability and vagal activity are detected not only in schizophrenia, but also in other mental and somatic disorders, in the pathogenesis of which distress is involved.
Conclusion. The possibility of using heart rate variability indicators as additional criteria for assessing the severity of psychosis, predicting the effectiveness of therapy, as well as for early stratification of cardiovascular risks requires further study in scientific research.
About the Authors
O. S. Antipova
Moscow Psychiatric Research Institute, a branch of the V.P. Serbsky National Medical Research Center for Psychiatry and Narcology (a Federal Government-funded Institution) Russian Federation Ministry of Health
Russian Federation
Russian Federation
3 Poteshnaya St., Bldg. 10, Moscow, 107076
M. K. Reznikov
LLC Detskii Doctor Plus
Russian Federation
Russian Federation
2/3 Begovaya Str., Voronezh, 394068
References
1. Kraepelin E. Psychiatry: а textbook for students and physicians. Canton, MA: Watson Publishing International; 1899/1990.
2. Hattori S., Suda A., Kishida I., Miyauchi M. et al. Association between dysfunction of autonomic nervous system activity and mortality in schizophrenia. Compr. Psychiatry. 2018; 86: 119–22. DOI: 10.1016/j.comppsych.2018.08.002
3. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005; 150(6): 1115–21. DOI: 10.1016/j.ahj.2005.02.007
4. Loas G., Azi A., Noisette C., Yon V. Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients. Encephale. 2008; 34(1): 54–60. DOI: 10.1016/j.encep.2007.07.005
5. Ringen P.A., Engh J.A., Birkenaes A.B., Dieset I. et al. Increased mortality in schizophrenia due to cardiovascular disease — nonsystematic review of epidemiology, possible causes, and interventions. Front. Psychiatry. 2014; 5: 137. DOI: 10.3389/fpsyt.2014.00137
6. Manu P., Kane J.M., Correll C.U. Sudden deaths in psychiatric patients. J. Clin. Psychiatry. 2011; 72(7): 936–41. DOI: 10.4088/JCP.10m06244gry
7. Beary M., Hodgson R., Wildgust H.J. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J. Psychopharmacol. 2012; 26(5 suppl.): 52–61. DOI: 10.1177/0269881112440512
8. Bokeria L.A., Bokeria O.L., Volkovskaya I.V. Heart rate variability: measurement methods, interpretation, clinical use. Annals of Arrhythmology. 2009; 6(4): 21–32. (in Russian)
9. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996; 93(5): 1043–65.
10. Baevsky R.M., Ivanov G.G., Chireikin L.V., Gavrilushkin A.P. et al. Analysis of heart rate variability using various electrocardiographic systems: guidelines. Izhevsk: Publishing House of Udmurt University; 2003: 201–55. (in Russian)
11. Liu Y., Huang Y., Zhou J., Li G. et al. Altered heart rate variability in patients with schizophrenia during an autonomic nervous test. Front. Psychiatry. 2021; 30(12): 626991. DOI: 10.3389/fpsyt.2021.626991
12. Chang J.S., Yoo C.S., Yi S.H., Hong K.H. et al. Differential pattern of heart rate variability in patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2009; 33(6): 991–5. DOI: 10.1016/j.pnpbp.2009.05.004
13. Mujica-Parodi L.R., Yeragani V., Malaspina D. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology. 2005; 51(1): 10–15. DOI: 10.1159/000082850
14. Clamor A., Lincoln T.M., Thayer J.F., Koenig J. Resting vagal activity in schizophrenia: meta-analysis of heart rate variability as a potential endophenotype. Br. J. Psychiatry. 2016; 208(1): 9–16. DOI: 10.1192/bjp.bp.114.160762
15. Montaquila J.M., Trachik B.J., Bedwell J.S. Heart rate variability and vagal tone in schizophrenia: a review. J. Psychiatr. Res. 2015; 69: 57–66. DOI: 10.1016/j.jpsychires.2015.07.025
16. Bär K.-J., Wernich K., Boettger S., Cordes J. et al., Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psych. Res. 2008; 157(1–3): 255–7. DOI: 10.1016/j.psychres.2007.04.021
17. Boettger S., Hoyer D., Falkenhahn K., Kaatz M. et al. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin. Neurophysiol. 2006; 117(12): 2715–22. DOI: 10.1016/j.clinph.2006.08.009
18. Birkhofer A., Geissendoerfer J., Alger P., Mueller A. et al. The deceleration capacity — a new measure of heart rate variability evaluated in patients with schizophrenia and antipsychotic treatment. Eur. J. Psychiatry. 2013; 28(2): 81–6. DOI: 10.1159/000452770
19. Thayer J.F., Lane R.D. A model of neurovisceral integration in emotion regulation and dysregulation. J. Affect. Disord. 2000; 61(3): 201–16. DOI: 10.1016/s0165-0327(00)00338-4
20. Akar S.A., Kara S., Latifoğlu F., Bilgiç V. Analysis of heart rate variability during auditory stimulation periods in patients with schizophrenia. J. Clin. Monit. Comput. 2015; 29(1): 153–62. DOI: 10.1007/s10877-014-9580-8
21. Bär K.-J., Letzsch A., Jochum T., Wagner G. et al. Loss of efferent vagal activity in acute schizophrenia. J. Psychiatr. Res. 2005; 39(5): 519–27. DOI: 10.1016/j.jpsychires.2004.12.007
22. Fujibayashi M., Matsumoto T., Kishida I., Kimura T. et al. Autonomic nervous system activity and psychiatric severity in schizophrenia. Psychiatry Clin. Neurosci. 2009; 63(4): 538–45. DOI: 10.1111/j.1440-1819.2009.01983.x
23. Ieda M., Miyaoka T., Wake R., Liaury K. et al. Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2014; 264(1): 83–7. DOI: 10.1007/s00406-013-0411-6
24. Moon E., Lee S.H., Kim D.H., Hwang B. Comparative study of heart rate variability in patients with schizophrenia, bipolar disorder, post-traumatic stress disorder, or major depressive disorder. Clin. Psychopharmacol. Neurosci. 2013; 11(3): 137–43. DOI: 10.9758/cpn.2013.11.3.137
25. Iwamoto Y., Kawanishi C., Kishida I., Furuno T. et al. Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia. BMC Psychiatry. 2012; 12: 199. DOI: 10.1186/1471-244X-12-199
26. Schulz S., Bolz M., Bär K.-J, Voss A. Central and autonomic nervous system coupling in schizophrenia. Philos. Trans. A Math. Phys. Eng. Sci. 2016; 374(2067): 20150178. DOI: 10.1098/rsta.2015.0178
27. Guccione C., Di Scalea G.L., Ambrosecchia M., Terrone G. et al. Early signs of schizophrenia and autonomic nervous system dysregulation: a literature review. Clin. Neuropsychiatry. 2019; 16(2): 86–97.
28. Bär K.-J. Cardiac autonomic dysfunction in patients with schizophrenia and their healthy relatives — a small review. Front. Neurol. 2015; 6: 139. DOI: 10.3389/fneur.2015.00139
29. Bär K.-J., Boettger M.K., Berger S., Baier V. et al. Decreased baroreflex sensitivity in acute schizophrenia. J. Appl. Physiol. 2007; 102(3): 1051–6. DOI: 10.1152/japplphysiol.00811.2006
30. Kudat H., Akkaya V., Sozen A.B., Salman S. et al. Heart rate variability in diabetes patients. J. Int. Med. Res. 2006; 34(3): 291–6. DOI: 10.1177/147323000603400308
31. Haigh S.M., Walford T.P., Brosseau P. Heart rate variability in schizophrenia and autism. Front. Psychyatry, 2021; 12: 760396. DOI: 10.3389/fpsyt.2021.760396
32. Bengtsson J., Olsson E., Igelström H., Persson J. et al. Ambulatory heart rate variability in schizophrenia or depression: impact of anticholinergic burden and other factors. J. Clin. Psychopharmacol. 2021; 41(2): 121–8. DOI: 10.1097/JCP.0000000000001356
33. Antipova O.S. Challenges and prospects for research on autonomic regulation in depression. Doctor.Ru 2019; 6(161): 42–6. (in Russian). DOI: 10.31550/1727-2378-2019-161-6-42-46
34. Beauchaine T.P., Thayer J.F. Heart rate variability as a transdiagnostic biomarker of psychopathology. Int. J. Psychophysiol. 2015; 98(2 Pt2): 338–50. DOI: 10.1016/j.ijpsycho.2015.08.004
35. Davydov D.M., Shapiro D., Cook I.A., Goldstein I. Baroreflex mechanisms in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007; 31(1): 164–77. DOI: 10.1016/j.pnpbp.2006.08.015
36. Holzman J.B., Bridgett D.J. Heart rate variability indices as biomarkers of top-down self-regulatory mechanisms: a metaanalytic review. Neurosci. Biobehav. Rev. 2017; 74 (PtA): 233–55. DOI: 10.1016/j.neubiorev.2016.12.032
37. La Rovere M.T., Bigger J.T. Jr, Marcus F.I., Mortara A. et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998; 351(9101): 478–84. DOI: 10.1016/s0140-6736(97)11144-8
38. La Rovere M.T., Pinna G.D., Hohnloser S.H., Marcus F.I. et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001; 103(16): 2072–7. DOI: 10.1161/01.cir.103.16.2072
39. Thayer J.F., Ahs F., Fredrikson M., Sollers J.J. 3rd et al. A metaanalysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci. Biobehav. Rev. 2012; 36(2): 747–56. DOI: 10.1016/j.neubiorev.2011.11.009
40. Bär K.-J., Berger S., Metzner M., Boettger M.K. et al. Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia. Schizophr. Bull. 2009; 36(5): 1050–8. DOI: 10.1093/schbul/sbp024
41. Valkonen-Korhonen M., Tarvainen M.P., Ranta-Aho P., Karjalainen P.A. et al. Heart rate variability in acute psychosis. Psychophysiology. 2003; 40(5): 716–26. DOI: 10.1111/1469-8986.00072
42. Hempel R.J., Tulen J.H., van Beveren N.J., van Steenis H.G. et al. Physiological responsivity to emotional pictures in schizophrenia. J. Psychiatr. Res. 2005; 39(5): 509–18. DOI: 10.1016/j.jpsychires.2004.11.004
43. Castro M.N., Vigo D.E., Weidema H., Fahrer R.D. et al. Heart rate variability response to mental arithmetic stress in patients with schizophrenia. Autonomic response to stress in schizophrenia. Schizophr. Res. 2008; 99(1–3): 294–303. DOI: 10.1016/j.schres.2007.08.025
44. Reed A.C., Lee J., Green M.F., Hamilton H.K. et al. Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia. Schizophr. Res. 2020; 218: 233–9. DOI: 10.1016/j.schres.2019.12.040
45. Khandoker A.H., Fujibayashi M., Moritani T., Palaniswami M. Assessing sympatho-vagal balance in schizophrenia through toneentropy analysis. Comp. Cardiol. 2010; 37: 69–72.
46. Benjamin B.R., Valstad M., Elvsåshagen T., Jönsson E.G. et al. Heart rate variability is associated with disease severity in psychosis spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021; 111: 110108. DOI: 10.1016/j.pnpbp.2020.110108
47. Chang H.A., Chang C.C., Tzeng N.S., Kuo T.B. et al. Cardiac autonomic dysregulation in acute schizophrenia. Acta Neuropsychiatr. 2013; 25(3): 155–64. DOI: 10.1111/acn.12014
48. Kim J.-H., Ann J.-H., Lee J. Relationship between heart rate variability and the severity of psychotic symptoms in schizophrenia. Acta Neuropsychiatr. 2011; 23(4): 161–6. DOI: 10.1111/j.1601-5215.2011.00549.x
49. Huang W.C., Liu W.S., Chen T.T., Chen W.H. et al. Parasympathetic activity as a potential biomarker of negative symptoms in patients with schizophrenia. Asia Pac. Psychiatry. 2020; 12(3): e12392. DOI: 10.1111/appy.12392
50. Peupelmann J., Boettger M.K., Ruhland C., Berger S. et al. Cardiorespiratory coupling indicates suppression of vagal activity in acute schizophrenia. Schizophr. Res. 2009; 112(1–3): 153–7. DOI: 10.1016/j.schres.2009.03.042
51. Henry B.L., Minassian A., Paulus M.P., Geyer M.A. et al. Heart rate variability in bipolar mania and schizophrenia. J. Psychiatr. Res. 2010; 44(3): 168–76. DOI: 10.1016/j.jpsychires.2009.07.011
52. Quintana D., Westlye L., Kaufmann T., Rustan O. et al. Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls. Acta Psychiatr. Scand. 2015; 133(1): 44–52. DOI: 10.1111/acps.12498
53. Mathewson K.J., Jetha M.K., Goldberg J.O., Schmidt L.A. Autonomic regulation predicts performance on Wisconsin Card Sorting Test (WCST) in adults with schizophrenia. Biol. Psychol. 2012; 91(3): 389–99. DOI: 10.1016/j.biopsycho.2012.09.002
54. Kimhy D., Wall M.M., Hansen M.C., Vakhrusheva J. et al. Autonomic regulation and auditory hallucinations in individuals with schizophrenia: an experience sampling study. Schizophr. Bull. 2017; 43(4): 754–63. DOI: 10.1093/schbul/sbw219
55. Reznikov M.K., Shiryaev O.Yu., Zhitkova S.N. The relationship of psychopharmacotherapy and heart rate variability in patients with schizophrenia. Journal of Scientific Articles. Health and Education in the XXI Century. Materials of the VIII International Congress “Health and Education in the 21st Century; Concept of Diseases of Civilization“. 2007; 9(2): 165. (in Russian)
56. Zhang T.H., Tang X.C., Xu L.H., Wei Y.Y. at al. Imbalance model of heart rate variability and pulse wave velocity in psychotic and nonpsychotic disorders. Schizophr. Bull. 2022. 48(1): 154–65. DOI: 10.1093/schbul/sbab080
57. Yuen J.W.Y., Kim D.D., Procyshyn R.M., White R.F. et al. Clozapineinduced cardiovascular side effects and autonomic dysfunction: a systematic review. Front. Neurosci. 2018; 12: 203. DOI: 10.3389/fnins.2018.00203
58. Agelink M.W., Majewski T., Wurthmann C., Lukas K. et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a сomparison between amisulpride, olanzapine, sertindole, and clozapine. J. Clin. Psychopharmacol. 2001; 21(1): 8–13. DOI: 10.1097/00004714-200102000-00003
59. Penttilä J., Kuusela T., Scheinin H. Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans. Eur. J. Clin. Pharm. 2005; 61(8): 559–65. DOI: 10.1007/s00228-005-0953-2
60. Cohen H., Loewenthal U., Matar M., Kotler M. Association of autonomic dysfunction and clozapine: heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br. J. Psychiatry. 2001; 179: 167–71. DOI: 10.1192/bjp.179.2.167
61. Wang Y.C., Yang C.C., Bai Y.M., Kuo T.B. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology. 2008; 57(4): 200–5. DOI: 10.1159/000149818
62. Hattori S., Kishida I., Suda A., Miyauchi M. et al. Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia. Schizophr. Res. 2018; 193: 134–8. DOI: 10.1016/j.schres.2017.07.004
63. Lee K., Park J., Choi J., Park C.G. Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia. J. Korean Acad. Nurs. 2011; 41(6): 788–94. DOI: 10.4040/jkan.2011.41.6.788
64. Kim J.A., Park Y.G., Cho K.H., Hong M.H. et al. Heart rate variability and obesity indices: emphasis on the response to noise and standing. J. Am. Board Fam. Med. 2005; 18(2): 97–103. DOI: 10.3122/jabfm.18.2.97
65. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A. et al. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005; 80(1): 19–32. DOI: 10.1016/j.schres.2005.07.014
66. Meyer J.M., Nasrallah H.A., McEvoy J.P., Goff D.C. et al. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr. Res. 2005; 80(1): 9–18. DOI: 10.1016/j.schres.2005.07.015
67. Stogios N., Gdanski A., Gerretsen P., Chintoh A.F. et al. Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health. NPJ Schizophr. 2021; 7(1): 22. DOI: 10.1038/s41537-021-00151-6
68. Hsu C.C., Liang C.S., Tai Y.M., Cheng S.L. Incongruent changes in heart rate variability and body weight after discontinuing aerobic exercise in patients with schizophrenia. Int. J. Psychophysiol. 2016; 109: 132–7. DOI: 10.1016/j.ijpsycho.2016.08.011
Review
For citations:
Antipova O.S., Reznikov M.K. Heart Rate Variability in Schizophrenia and Shizoaffective Disorder. Title. 2022;21(4):72-78. (In Russ.) https://doi.org/10.31550/1727-2378-2022-21-4-72-78
Views:
27
Email this article 